2.08 USD
0.21 (11.15%)
Last updated Dec 6, 2:30 PM
Yesterday High
$1.98
Yesterday Low
$1.78
52w High
$22.70
52w Low
$0.82
Market Cap.
$26.8M
52w Change
-90.82%
This is a preview of the full version of Prosperse
Trending News
Annovis Bio (NYSE: ANVS) to Present at H.C. Wainwright 26th Annual Global Investment Conference
Annovis Bio, a late-stage clinical drug platform company, announced that its Founder, President, and CEO, Maria L. Maccecchini, Ph.D., will participate in the upcoming H.C. Wainwright 26th Annual Global Investment Conference, including a company presentation and a panel discussion on non-amyloid app...
N/A
Sep 5, 2024
Longeveron® Presents Study Results from CLEAR MIND Phase 2a Clinical Trial of Lomecel-B™ in Mild Alzheimer’s Disease at the Alzheimer’s Association In...
Longeveron announced positive results from its Phase 2a CLEAR MIND clinical trial of Lomecel-B in mild Alzheimer's disease, showing improvements in cognitive function, quality of life, and brain volume.
N/A
Jul 28, 2024
Login to view more news
Dive into the world of investing with Prosperse
Explore our recent articles to learn more about how Prosperse can help you achieve your financial goals.
Read more news from Prosperse
Nvidia and Google Partner to Propel Quantum Computing Processor Development
Date: Nov 19, 2024
Netflix’s Boxing Spectacle Challenges Streaming Capabilities, Pushing Ambitions in Live Sports
Date: Nov 19, 2024
Leading AI Companies Face Diminishing Returns in Model Advancement
Date: Nov 14, 2024
Meta Platforms Inc. Introduces Orion: A Glimpse into the Future of Augmented Reality
Date: Nov 14, 2024
Meta Platforms Inc.'s Stock Rises Despite Challenges Following Trump's Re-election
Date: Nov 14, 2024